These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18775075)

  • 41. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug/nondrug classification using Support Vector Machines with various feature selection strategies.
    Korkmaz S; Zararsiz G; Goksuluk D
    Comput Methods Programs Biomed; 2014 Nov; 117(2):51-60. PubMed ID: 25224081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural features embedded in G protein-coupled receptor co-crystal structures are key to their success in virtual screening.
    Coudrat T; Christopoulos A; Sexton PM; Wootten D
    PLoS One; 2017; 12(4):e0174719. PubMed ID: 28380046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GPCR structure-based virtual screening approach for CB2 antagonist search.
    Chen JZ; Wang J; Xie XQ
    J Chem Inf Model; 2007; 47(4):1626-37. PubMed ID: 17580929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemogenomic analysis of G-protein coupled receptors and their ligands deciphers locks and keys governing diverse aspects of signalling.
    Wichard JD; Ter Laak A; Krause G; Heinrich N; Kühne R; Kleinau G
    PLoS One; 2011 Feb; 6(2):e16811. PubMed ID: 21326864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrating statistical predictions and experimental verifications for enhancing protein-chemical interaction predictions in virtual screening.
    Nagamine N; Shirakawa T; Minato Y; Torii K; Kobayashi H; Imoto M; Sakakibara Y
    PLoS Comput Biol; 2009 Jun; 5(6):e1000397. PubMed ID: 19503826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of carbohydrate binding modules in extracellular region of class C G-protein coupled receptors (C GPCR): An
    Kashani-Amin E; Sakhteman A; Larijani B; Ebrahim-Habibi A
    J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An ontology for pharmaceutical ligands and its application for in silico screening and library design.
    Schuffenhauer A; Zimmermann J; Stoop R; van der Vyver JJ; Lecchini S; Jacoby E
    J Chem Inf Comput Sci; 2002; 42(4):947-55. PubMed ID: 12132896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Snooker: a structure-based pharmacophore generation tool applied to class A GPCRs.
    Sanders MP; Verhoeven S; de Graaf C; Roumen L; Vroling B; Nabuurs SB; de Vlieg J; Klomp JP
    J Chem Inf Model; 2011 Sep; 51(9):2277-92. PubMed ID: 21866955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homology model-assisted elucidation of binding sites in GPCRs.
    Levit A; Barak D; Behrens M; Meyerhof W; Niv MY
    Methods Mol Biol; 2012; 914():179-205. PubMed ID: 22976029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting GPCR-G-protein coupling using hidden Markov models.
    Sreekumar KR; Huang Y; Pausch MH; Gulukota K
    Bioinformatics; 2004 Dec; 20(18):3490-9. PubMed ID: 15297294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemical Diversity in the G Protein-Coupled Receptor Superfamily.
    Vass M; Kooistra AJ; Yang D; Stevens RC; Wang MW; de Graaf C
    Trends Pharmacol Sci; 2018 May; 39(5):494-512. PubMed ID: 29576399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using silico methods predicting ligands for orphan GPCRs.
    Jiang Z; Zhou Y
    Curr Protein Pept Sci; 2006 Oct; 7(5):459-64. PubMed ID: 17073696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assay Related Target Similarity (ARTS) - chemogenomics approach for quantitative comparison of biological targets.
    Bieler M; Heilker R; Köppen H; Schneider G
    J Chem Inf Model; 2011 Aug; 51(8):1897-905. PubMed ID: 21761911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Machine Learning Approach for the Discovery of Ligand-Specific Functional Mechanisms of GPCRs.
    Plante A; Shore DM; Morra G; Khelashvili G; Weinstein H
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31159491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.